Literature DB >> 16392902

Real-time PCR analysis of trinucleotide repeat allele expansions in the androgen receptor gene.

Anthoula Chatzikyriakidou1, Christos Yapijakis, Nikolaos Sofikitis, Dimitrios Vassilopoulos, Ioannis Georgiou.   

Abstract

INTRODUCTION: The expansion of specific trinucleotide repeats results in certain genetic disorders.
METHOD: Real-time PCR analysis was used to rapidly discriminate between normal and expanded (CAG)(n) alleles in the androgen receptor gene. RESULT: The difference in melting temperature (T(m)) between the most common normal and expanded alleles was approximately 1 degrees C.
CONCLUSION: Real-time PCR analysis seems to be a highly reliable and rapid method, which may facilitate the first molecular approach to human trinucleotide repeat disorders.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16392902     DOI: 10.1007/BF03260095

Source DB:  PubMed          Journal:  Mol Diagn        ISSN: 1084-8592


  12 in total

1.  Androgen receptor gene mutations in X-linked spinal and bulbar muscular atrophy.

Authors:  A R La Spada; E M Wilson; D B Lubahn; A E Harding; K H Fischbeck
Journal:  Nature       Date:  1991-07-04       Impact factor: 49.962

2.  Fluorescent PCR and automated fragment analysis for the clinical application of preimplantation genetic diagnosis of myotonic dystrophy (Steinert's disease).

Authors:  K Sermon; A De Vos; H Van de Velde; S Seneca; W Lissens; H Joris; M Vandervorst; A Van Steirteghem; I Liebaers
Journal:  Mol Hum Reprod       Date:  1998-08       Impact factor: 4.025

3.  Prenatal diagnosis of X-linked spinal and bulbar muscular atrophy in a Greek family.

Authors:  C Yapijakis; E Kapaki; M Boussiou; D Vassilopoulos; C Papageorgiou
Journal:  Prenat Diagn       Date:  1996-03       Impact factor: 3.050

4.  Founder effect in spinal and bulbar muscular atrophy (SBMA) in Scandinavia.

Authors:  A Lund; B Udd; V Juvonen; P M Andersen; K Cederquist; L O Ronnevi; P Sistonen; S A Sörensen; L Tranebjaerg; C Wallgren-Pettersson; M L Savontaus
Journal:  Eur J Hum Genet       Date:  2000-08       Impact factor: 4.246

5.  Preimplantation diagnosis for fragile X syndrome based on the detection of the non-expanded paternal and maternal CGG.

Authors:  K Sermon; S Seneca; A Vanderfaeillie; W Lissens; H Joris; M Vandervorst; A Van Steirteghem; I Liebaers
Journal:  Prenat Diagn       Date:  1999-12       Impact factor: 3.050

6.  Spinal and bulbar muscular atrophy: androgen receptor dysfunction caused by a trinucleotide repeat expansion.

Authors:  H E MacLean; G L Warne; J D Zajac
Journal:  J Neurol Sci       Date:  1996-02       Impact factor: 3.181

7.  CAG repeat polymorphism in the androgen receptor (AR) gene of SBMA patients and a control group.

Authors:  Anna Sułek; Dorota Hoffman-Zacharska; Wioletta Krysa; Walentyna Szirkowiec; Elzbieta Fidziańska; Jacek Zaremba
Journal:  J Appl Genet       Date:  2005       Impact factor: 3.240

8.  Structural and functional consequences of glutamine tract variation in the androgen receptor.

Authors:  Grant Buchanan; Miao Yang; Albert Cheong; Jonathan M Harris; Ryan A Irvine; Paul F Lambert; Nicole L Moore; Michael Raynor; Petra J Neufing; Gerhard A Coetzee; Wayne D Tilley
Journal:  Hum Mol Genet       Date:  2004-06-15       Impact factor: 6.150

9.  Stability of an expanded trinucleotide repeat in the androgen receptor gene in transgenic mice.

Authors:  P M Bingham; M O Scott; S Wang; M J McPhaul; E M Wilson; J Y Garbern; D E Merry; K H Fischbeck
Journal:  Nat Genet       Date:  1995-02       Impact factor: 38.330

10.  Preimplantation diagnosis for Huntington's disease (HD): clinical application and analysis of the HD expansion in affected embryos.

Authors:  K Sermon; V Goossens; S Seneca; W Lissens; A De Vos; M Vandervorst; A Van Steirteghem; I Liebaers
Journal:  Prenat Diagn       Date:  1998-12       Impact factor: 3.050

View more
  1 in total

Review 1.  Mutant Ataxin-3-Containing Aggregates (MATAGGs) in Spinocerebellar Ataxia Type 3: Dynamics of the Disorder.

Authors:  Kritika Raj; Ravi Shankar Akundi
Journal:  Mol Neurobiol       Date:  2021-02-24       Impact factor: 5.590

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.